Abstract
Acute heart failure (AHF) is defined as the rapid onset of, or changes in, the symptoms and signs of heart failure (HF). It is a life-threatening situation in which diagnosis and initiation of therapy are crucial. The treatment aims are to stabilize the patient, improve clinical symptoms, and increase long-term survival rates. Few treatments have been investigated in clinical trials. This review summarizes the principles of pharmacologic treatment, the underlying clinical trials, and new pharmacologic targets.
MeSH terms
-
Acute Disease
-
Analgesics, Opioid / therapeutic use
-
Cardiotonic Agents / therapeutic use
-
Diuretics / therapeutic use
-
Drugs, Investigational / therapeutic use*
-
Heart Failure / drug therapy*
-
Humans
-
Molecular Targeted Therapy / trends*
-
Opioid Peptides
-
Oxygen / therapeutic use
-
Practice Guidelines as Topic
-
Vasoconstrictor Agents / therapeutic use
-
Vasodilator Agents / therapeutic use
Substances
-
Analgesics, Opioid
-
Cardiotonic Agents
-
Diuretics
-
Drugs, Investigational
-
Opioid Peptides
-
Vasoconstrictor Agents
-
Vasodilator Agents
-
Oxygen